“Ruby” is a family of structurally related ingredients with applications in food, personal care and other markets. The identity of the Ruby family is not yet public.

In 2012, Evolva partnered certain ingredients in the Ruby family with Roquette (Lestrem, France). The partnership involves pathway creation, strain improvement and scale-up. Roquette has exclusivity for certain ingredients within the Ruby family, whilst Evolva retains all rights to others.

The partnership has progressed well, with all milestones achieved on or ahead of plan. In 2014, Roquette paid Evolva research fees and a milestone payment. Evolva’s work on the collaboration is expected to complete in summer 2015, with Evolva due a one-off payment dependent on the commercial value of the specific ingredient.

After completion of the program in summer 2015 Evolva anticipates further developing and commercialising certain of the Ruby ingredients that it retains rights to.


  • Adding molecules to food, pros & cons

    Nobody much cares how medicines are made, so long as they heal. Different story with food ingredients. This article teases out why.

    Reviews in Food Science
  • Biotech in your vanilla ice cream ?

    The Motley Fool is one of those very rare members of the media that still have fun doing good financial analysis, business reporting, and contrarian journalism.

    The Motley Fool
More articles
  • Topped our upper estimate! Evolva raises CHF 86M ($86M). Cash position now > CHF 100M ($100M).

Sign up to receive our
Press Releases!

Sign up